Total Payments
$2,462
2024 Payments
$708.71
Companies
12
Transactions
108
Medicare Patients
973
Medicare Billing
$174,328
Payment Breakdown by Category
Food & Beverage$2,116 (85.9%)
Travel$346.44 (14.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,116 | 106 | 85.9% |
| Travel and Lodging | $346.44 | 2 | 14.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,058 | 40 | $0 (2024) |
| ABBVIE INC. | $694.54 | 34 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $314.02 | 17 | $0 (2024) |
| Axsome Therapeutics, Inc. | $145.35 | 6 | $0 (2024) |
| ITI, Inc. | $61.22 | 2 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $39.56 | 2 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33.58 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $29.11 | 1 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $26.46 | 1 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $23.57 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $708.71 | 37 | Otsuka America Pharmaceutical, Inc. ($197.93) |
| 2023 | $1,176 | 39 | Janssen Pharmaceuticals, Inc ($699.75) |
| 2022 | $482.80 | 29 | ABBVIE INC. ($231.28) |
| 2021 | $94.84 | 3 | AbbVie Inc. ($62.76) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Neuroscience | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $60.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Neuroscience | ||||||
| 07/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Neuroscience | ||||||
| 07/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: PSYCHIATRY | ||||||
| 05/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Neuroscience | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: PSYCHIATRY | ||||||
| 05/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Neuroscience | ||||||
| 04/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 412 | 1,420 | $241,740 | $84,076 |
| 2022 | 5 | 379 | 1,482 | $198,450 | $72,127 |
| 2021 | 2 | 121 | 148 | $18,942 | $11,781 |
| 2020 | 2 | 61 | 79 | $8,944 | $6,344 |
Total Patients
973
Total Services
3,129
Medicare Billing
$174,328
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 142 | 913 | $165,923 | $45,800 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 137 | $21,113 | $10,419 | 49.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 83 | 85 | $19,209 | $9,269 | 48.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 27 | 43 | $7,488 | $5,414 | 72.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 64 | $13,300 | $4,804 | 36.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 31 | 83 | $5,692 | $3,491 | 61.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 20 | 77 | $5,357 | $2,988 | 55.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $3,659 | $1,891 | 51.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 131 | 602 | $42,140 | $24,968 | 59.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 95 | 504 | $100,800 | $22,972 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 105 | $16,800 | $8,225 | 49.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 54 | 117 | $24,570 | $7,666 | 31.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 43 | 130 | $9,100 | $5,843 | 64.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $5,040 | $2,452 | 48.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 76 | 93 | $9,223 | $7,017 | 76.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 20 | $3,594 | $2,500 | 69.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 35 | $6,125 | $2,264 | 37.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 42 | 60 | $6,021 | $4,289 | 71.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 19 | 19 | $2,923 | $2,055 | 70.3% |
About Tasha Preston, ARNP
Tasha Preston, ARNP is a Psychiatric/Mental Health healthcare provider based in Ardmore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2010. The National Provider Identifier (NPI) number assigned to this provider is 1811205925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tasha Preston, ARNP has received a total of $2,462 in payments from pharmaceutical and medical device companies, with $708.71 received in 2024. These payments were reported across 108 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,116).
As a Medicare-enrolled provider, Preston has provided services to 973 Medicare beneficiaries, totaling 3,129 services with total Medicare billing of $174,328. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Family
- Location Ardmore, OK
- Active Since 09/23/2010
- Last Updated 10/29/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1811205925
Products in Payments
- SPRAVATO (Drug) $851.69
- VRAYLAR (Drug) $694.54
- INVEGA SUSTENNA (Drug) $196.94
- ABILIFY ASIMTUFII (Drug) $179.66
- Auvelity (Drug) $145.35
- CAPLYTA (Drug) $94.80
- ABILIFY MAINTENA (Drug) $86.66
- REXULTI (Drug) $69.14
- INGREZZA (Drug) $39.56
- AUSTEDO (Drug) $29.11
- FANAPT (Drug) $26.46
- NUZYRA (Drug) $23.57
- INVEGA TRINZA (Drug) $9.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Ardmore
Miss. Janelle Stank, Crnp, CRNP
Psychiatric/Mental Health — Payments: $443.61
Psychiatric/Mental Health $443.61
Christologus Obi, Aprn-Cnp, Pmhnp, APRN-CNP, PMHNP
Psychiatric/Mental Health — Payments: $65.36
Psychiatric/Mental Health $65.36
Tawnya Peery, Aprn, APRN
Psychiatric/Mental Health — Payments: $62.76
Psychiatric/Mental Health $62.76
Sarah Knox, Crnp, CRNP
Psychiatric/Mental Health
Psychiatric/Mental Health
Vena Tawkoyty, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health
Psychiatric/Mental Health
Mercy Antony
Psychiatric/Mental Health
Psychiatric/Mental Health